(Q39018864)

English

Novel perspectives for hepatitis A virus therapy revealed by comparative analysis of hepatitis C virus and hepatitis A virus RNA replication

scientific article published on 11 April 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Novel perspectives for hepatitis A virus therapy revealed by comparative analysis of hepatitis C virus and hepatitis A virus RNA replication (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

1 reference

based on heuristic

inferred from title

Hepatitis C virus

1 reference

based on heuristic

inferred from title

Hepatitis A virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

author name string

Katharina Esser-Nobis

1

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Christian Harak

2

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Philipp Schult

3

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Yuri Kusov

4

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

language of work or name

0 references

publication date

11 April 2015

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

62

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

397-408

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Failure of innate and adaptive immune responses in controlling hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27847

21 January 2018

Acute hepatitis A virus infection is associated with a limited type I interferon response and persistence of intrahepatic viral RNA.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27847

21 January 2018

Hepatitis A and E: update on prevention and epidemiology

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27847

21 January 2018

Outbreak of hepatitis A in the USA associated with frozen pomegranate arils imported from Turkey: an epidemiological case study.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27847

21 January 2018

Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27847

21 January 2018

The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27847

21 January 2018

Viral reorganization of the secretory pathway generates distinct organelles for RNA replication

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27847

21 January 2018

Recruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartment

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27847

21 January 2018

Metabolism of phosphatidylinositol 4-kinase IIIα-dependent PI4P Is subverted by HCV and is targeted by a 4-anilino quinazoline with antiviral activity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27847

21 January 2018

Class III Phosphatidylinositol 4-Kinase Alpha and Beta Are Novel Host Factor Regulators of Hepatitis C Virus Replication

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27847

21 January 2018

Multiple cyclophilins involved in different cellular pathways mediate HCV replication

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27847

21 January 2018

Small-molecule multidrug resistance-associated protein 1 inhibitor reversan increases the therapeutic index of chemotherapy in mouse models of neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27847

21 January 2018

Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27847

21 January 2018

Identification of Determinants Involved in Initiation of Hepatitis C Virus RNA Synthesis by Using Intergenotypic Replicase Chimeras

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27847

21 January 2018

Essential Role of Cyclophilin A for Hepatitis C Virus Replication and Virus Production and Possible Link to Polyprotein Cleavage Kinetics

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27847

21 January 2018

Replication of a hepatitis A virus replicon detected by genetic recombination in vivo

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27847

21 January 2018

Analysis of hepatitis C virus resistance to silibinin in vitro and in vivo points to a novel mechanism involving nonstructural protein 4B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27847

21 January 2018

A Comprehensive Structure-Function Comparison of Hepatitis C Virus Strain JFH1 and J6 Polymerases Reveals a Key Residue Stimulating Replication in Cell Culture across Genotypes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27847

21 January 2018

Cyclophilins as modulators of viral replication

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27847

21 January 2018

Cyclophilin inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27847

21 January 2018

Interaction of cyclosporin derivatives with the ATPase activity of human P-glycoprotein

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27847

21 January 2018

ABC multidrug transporters: structure, function and role in chemoresistance.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27847

21 January 2018

Silybin and the liver: from basic research to clinical practice.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27847

21 January 2018

Hepatitis A virus: from discovery to vaccines

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27847

21 January 2018

Simultaneous detection of hepatitis C virus and interferon stimulated gene expression in infected human liver

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27847

21 January 2018

Interferon lambda alleles predict innate antiviral immune responses and hepatitis C virus permissiveness

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27847

21 January 2018

Complete replication of hepatitis C virus in cell culture

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27847

21 January 2018

Rapid and convenient assays to assess potential inhibitory activity on in vitro hepatitis A replication

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27847

21 January 2018

The role of phosphatidylinositol 4-kinases and phosphatidylinositol 4-phosphate during viral replication

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27847

21 January 2018

Hepatitis A virus and the origins of picornaviruses

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27847

21 January 2018

Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27847

21 January 2018

Potent nonimmunosuppressive cyclophilin inhibitors with improved pharmaceutical properties and decreased transporter inhibition

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27847

21 January 2018

From chemical tools to clinical medicines: nonimmunosuppressive cyclophilin inhibitors derived from the cyclosporin and sanglifehrin scaffolds

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27847

21 January 2018

Profile of alisporivir and its potential in the treatment of hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27847

21 January 2018

Silymarin for HCV infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27847

21 January 2018

Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27847

21 January 2018

Hepatitis C virus RNA replication

1 reference

https://pubmed.ncbi.nlm.nih.gov/25866017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outbreak of hepatitis A infection associated with the consumption of frozen berries, Ireland, 2013--linked to an international outbreak

1 reference

https://pubmed.ncbi.nlm.nih.gov/25866017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/HEP.27847

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

PMC publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39018864&oldid=1802937717"